A detailed history of Leverty Financial Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Leverty Financial Group, LLC holds 3,067 shares of BSX stock, worth $257,689. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,067
Previous 3,120 1.7%
Holding current value
$257,689
Previous $240,000 7.08%
% of portfolio
0.14%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$72.96 - $84.0 $3,866 - $4,452
-53 Reduced 1.7%
3,067 $257,000
Q2 2024

Jul 15, 2024

SELL
$67.33 - $77.71 $5,049 - $5,828
-75 Reduced 2.35%
3,120 $240,000
Q1 2024

Apr 23, 2024

BUY
$57.6 - $68.62 $184,032 - $219,240
3,195 New
3,195 $218,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Leverty Financial Group, LLC Portfolio

Follow Leverty Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leverty Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leverty Financial Group, LLC with notifications on news.